Sharon Bio-Medicine informs about unaudited financial results

07 Feb 2022 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirement) Regulations, 2015 Sharon Bio-Medicine has informed that it enclosed the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021 along with the Limited Review Report issued by E.A Patil & Associates LLP, Statutory Auditors of the Company. The meeting commenced at 12 pm and concluded at 3 pm.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1493.35
Dr. Reddys Lab 5879.05
Cipla 1358.80
Zydus Lifesciences 967.80
Lupin 1585.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.